3 - 4 October 2019

MarketsandMarkets Biomarker and Companion Diagnostics Conference

Radisson Blu Edwardian, Grafton Hotel, London
5 +
Sessions
20+
Speakers
150
Attendees
10+
Networking Hours

Redefining clinical stage biomarker strategies for a successful CDx commercialization

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon. The conference will address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

users

20+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Challenges in NGS based CDx and the Importance of imaging biomarkers for precision medicine.

users

Opportunity to develop long-lasting business relationships and networking opportunities with senior peers. Get the Opportunity to get your queries handled by Biomarker experts in one on one session.

users

Facilitated networking sessions to ensure quality interactions along with Case studies from experts who have successfully created and developed a biomarker

WHAT TO EXPECT
Sessions

Clinical Biomarker Identification & Qualification

Biomarker and Personalized Medicine

Commercializing Biomarker in Therapeutic and Companion Diagnostic Applications

 

Key Highlights

Clinical biomarker identification and qualification

Biomarkers and personalized medicine

Assay development and validation

NGS and novel technologies in biomarker discovery

Commercialization of biomarkers in therapeutic and CDx applications

Who Should Attend

Researchers, scientists, clinicians, academicians and professionals

From Pharmaceutical companies, Bio-pharma companies, Universities and Research Institutes.

Departments:

Biomarker discovery/development | Translational research | Clinical Biomarker | Biomarkers in IO and Neurological disorders

CONFERENCE AGENDA
COMMERCIALIZING BIOMARKERS IN THERAPEUTIC AND COMPANION DIAGNOSTIC APPLICATIONS
CONFERENCE SPEAKERS
Advisors
Stephanie Traub

Stephanie Traub

Biomaker Development Specialist
Cancer Research UK

Stephanie Traub

Biomaker Development Specialist
Cancer Research UK
Thomas Joos

Thomas Joos

Deputy Managing Director
University of Tübingen

Thomas Joos

Deputy Managing Director
University of Tübingen
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Dr. Ian Pike

Dr. Ian Pike

Chief Scientific Officer
Proteome Sciences PLC

Dr. Ian Pike

Chief Scientific Officer
Proteome Sciences PLC
Stephanie Traub

Stephanie Traub

Biomaker Development Specialist
Cancer Research UK

Stephanie Traub

Biomaker Development Specialist
Cancer Research UK
Thomas Joos

Thomas Joos

Deputy Managing Director
University of Tübingen

Thomas Joos

Deputy Managing Director
University of Tübingen
Dan Sikkema

Dan Sikkema

Vice President
Quanterix

Dan Sikkema

Vice President
Quanterix
Peter Parker

Peter Parker

Director of the CRUK KHP Centre and Professor of Cancer Cell Biology
KCL

Peter Parker

Director of the CRUK KHP Centre and Professor of Cancer Cell Biology
KCL
Dr. Richardus Vonk

Dr. Richardus Vonk

VP, Head Oncology Statistics and Data Management
Bayer AG

Dr. Richardus Vonk

VP, Head Oncology Statistics and Data Management
Bayer AG
Yong-Jie Lu

Yong-Jie Lu

Professor of Molecular Oncology (Barts Cancer Institute)
Queen Mary University of London (QMUL)

Yong-Jie Lu

Professor of Molecular Oncology (Barts Cancer Institute)
Queen Mary University of London (QMUL)
SPONSORS
Gold
example-image

Proteome Sciences

Sponsors & Exhibitors
example-image

Quanterix

example-image

Adaptive Biotechnologies

example-image

Tissue Solutions

example-image

Olink Proteomics

example-image

Invivoscribe

example-image

Intertek

example-image

Myriad RBM

example-image

Mursla

example-image

Ultivue

PARTNERS
Supporting Association
BioAlps

BioAlps

Media Partners
example-image

PharmaTutor

example-image

PharmaVOICE

example-image

CrowdReviews.com

example-image

SciDoc Publishers

example-image

Digital Biomarkers

LOCATION
Radisson Blu Edwardian, Grafton Hotel, London
  • Radisson Blu Edwardian, Grafton 1
  • Radisson Blu Edwardian, Grafton
    About the Hotel

    For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

    Hotel Booking Link

     You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

    PAST EVENT GALLERY